Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Liver immune cells contain inert HIV and are unlikely to reproduce infection, study reveals

Liver immune cells contain inert HIV and are unlikely to reproduce infection, study reveals

In a proof-of-principle study, researchers at Johns Hopkins revealed that certain immune system cells found in the human liver, called liver macrophages, contain only inert HIV and aren’t likely to reproduce infection on their own in HIV-infected people on long-term antiretroviral therapy (ART). ART is a regimen containing combinations of HIV-targeting drugs that prevents the growth of the virus but does not eradicate it.

The report on the findings, published in the October issue of the Journal of Clinical Investigation, revealed that although inactive, HIV can remain in liver immune cells after more than 10 years of ART. However, the researchers say there is no evidence that it can be considered an HIV reservoir in this state because the virus can’t replicate at high levels.

This revelation supports the idea that when developing HIV treatments, liver macrophages can be ruled out as a cell type that may act as a reservoir of the virus. The researchers argue that it may not be important to address curing liver macrophage infection, thereby narrowing targets for treatment.

“Our study was the first, to our knowledge, that looked at whether liver macrophages also served as reservoirs, similar to CD4+ T cells, in ART-suppressed, HIV-infected people,” says Ashwin Balagopal, M.D., associate professor of medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine and senior author of the study. “We zeroed in on the liver since liver macrophages comprise 80 to 90 percent of all macrophages in the body,” notes Balagopal.

According to the Centers for Disease Control and Prevention, 36.7 million people worldwide and 1.1 million people in the United States are infected with HIV. Commonly, ART is used to suppress the replication of HIV and control the progression of AIDS in humans. The virus infects the body’s immune system–the white blood cells also referred to as T cells and macrophages.

The most common reservoirs in humans are in immune cells called resting memory CD4+ T cells. Even when ART suppresses HIV, the virus can remain hidden in cellular reservoirs. The interruption or discontinuation of ART can spread HIV to new cells because the virus becomes active and begins replicating again.

“Although it is well-established that macrophages are a natural target for HIV infection, for many years researchers have not known whether macrophages also harbor HIV in a reservoir during long-term ART, similar to the resting memory CD4+ T cells,” adds Balagopal.

The inability to wipe out reservoirs of infectious HIV has for decades frustrated efforts to completely cure the infection. In addition, it means that the interruption or discontinuation of ART at any time reactivates HIV replication, spreading the virus to new cells.

Balagopal and his team examined if any HIV reservoirs remained in populations of tissue macrophages that reside in livers; specifically, he looked for latent HIV-1, the most common strain of the virus, in liver macrophages.

“The other organs we could have examined that contain macrophages include the brain, heart, lungs and skin,” says Abraham Kandathil, Ph.D., research associate in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine, who performed all key experiments. “Macrophages can be scarce in these organs in comparison to the liver, and therefore are even more difficult to obtain than liver macrophages in sufficiently large numbers,” concludes Kandathil.

To determine if liver macrophages serve as a reservoir of infection-capable HIV-1 after ART, liver tissue samples were taken from nine HIV-1 infected persons, seven of whom underwent liver transplantation at The Johns Hopkins Hospital and otherwise would have had their livers discarded because they were no longer functional and/or cancerous.

Eight of the nine persons were on ART for periods ranging from eight months to approximately 12 years.

Using lab techniques that separate out the liver macrophages, the researchers found HIV-1 to be present in the macrophages even after exposure to longstanding virus-suppressing ART.

“However, when we tried to simulate virus “rebound” by activating liver macrophages to see if the virus was infectious or noninfectious, we found HIV-1 at low levels, without the ability to replicate at high levels needed to re-establish infection,” says Kandathil.

By examining the virus in these liver samples and separating out the liver macrophages, the researchers found HIV-1 to be present in the macrophages of one person among the group who took suppressive ART for almost 12 years. However, the virus was still determined to be inert, otherwise unable to replicate itself and spread.

The researchers conclude that while liver macrophages might harbor HIV-1 for a long time, it’s unlikely these viruses could continue an infection on their own, and they are unlikely to function as a reservoir because the viruses were not able to replicate.

In the future, Balagopal says, more research is needed to determine if the inert HIV-1 infected liver macrophages have any functional significance in people taking ART because expression of defective HIV-1 proteins can confuse the immune system and cause tissue inflammation.

“While we have potentially ruled out the liver as an infectious reservoir, it’s important to identify all of the relevant virus reservoirs in the body, such as the brain, since it’s likely that the virus hides in the DNA of different cell types and will require different strategies to cure,” says Balagopal. “Then we can move forward to finding a ‘functional’ HIV-1 cure that’s comprehensive.”

The researchers caution that their study is limited because of the small number of liver macrophages and human samples studied. In addition, the small number of CD4+ T cells (less than or equal to 1 percent) in the liver macrophage cultures may affect the researchers’ ability to detect them, although they say it is virtually impossible for contamination of 1 percent or less to have confounded the findings.

Source:

https://www.hopkinsmedicine.org/news/newsroom/news-releases/hiv-in-liver-cells-found-to-be-inactive-narrowing-potential-treatment-targets

Tagged with:

About author

Related Articles